NCT00216372 2020-11-05Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal CarcinomatosisIpsenPhase 3 Completed80 enrolled
NCT00332696 2011-09-23Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal CarcinomatosisNovartisPhase 2 Completed64 enrolled 17 charts